Please Support Our NICE Campaign Appeal

4 Dec. 2010

On 4th March 2010, NICE published their final decision not to recommend the use of azacitidine (Vidaza) to treat patients with MDS in the NHS, despite its proven ability to extend patient survival and significantly improve quality of life.

MDS UK Patient Support Group is one of the groups appealing the NICE decision on 1 June 2010.

Please sign a petition asking the Prime Minister to ensure treatment for MDS patients in the UK matches the rest of Europe.

Check our campaigns page for more ways you can help out before the appeal on 1st June 2010.

Please sign a petition asking the Prime Minister to ensure treatment for MDS patients in the UK matches the rest of Europe.

Check our campaigns page for more ways you can help out before the appeal on 1st June 2010.